Journal of Cutaneous Medicine and Surgery
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Comparison of Dermatologists' and Nondermatologists' Diagnostic Accuracy for Malignant Melanoma
2012
-
Is Access to Care Associated With Stage at Presentation and Survival for Melanoma Patients?.
23:586-594.
2019
-
Canadian Patients’ Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys.
22:464-471.
2018
-
A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in Adults.
22:78-83.
2018
-
Undergraduate Dermatology Education in Canada: A National Survey.
22:31-37.
2018
-
Acitretin Use in Dermatology.
21:2S-12S.
2017
-
Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition.
21:2S-40S.
2017
-
An Open Letter to Health Canada.
21:195-196.
2017
-
Review of Systemic Treatment Options for Adult Atopic Dermatitis.
21:31-39.
2017
-
2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009.
20:375-431.
2016
-
Acral Hemorrhagic Darier’s Disease.
20:478-480.
2016
-
Psoronychomycosis.
20:279-280.
2016
-
Non-melanoma Skin Cancer in Canada Chapter 2: Primary Prevention of Non-melanoma Skin Cancer (vol 19, pg 216, 2015).
19:604-604.
2015
-
Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses (vol 19, 227, 2015).
19:604-604.
2015
-
The Relationship Between Dermatologist- and Patient-Reported Acne Severity Measures and Treatment Recommendations.
19:464-469.
2015
-
Non-melanoma Skin Cancer in Canada Chapter 2: Primary Prevention of Non-melanoma Skin Cancer.
19:216-226.
2015
-
Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses.
19:227-238.
2015
-
Paradoxical, Cupping-Induced Localized Psoriasis: A Koebner Phenomenon.
19:320-322.
2015
-
Use of Facebook as a Tool for Knowledge Dissemination in Dermatology.
18:341-344.
2014
-
A Consensus on Acne Management Focused on Specific Patient Features.
18:243-255.
2014
-
Surface Anatomy of the Ear.
18:137-140.
2014
-
Clinical features of external genital warts..
17 Suppl 2:S55-S60.
2013
-
Managing external genital warts: practical aspects of treatment and prevention..
17 Suppl 2:S68-S75.
2013
-
Therapeutic options for external genital warts..
17 Suppl 2:S61-S67.
2013
-
Understanding genital warts: epidemiology, pathogenesis, and burden of disease of human papillomavirus..
17 Suppl 2:S47-S54.
2013
-
One-Year, Multicenter, Open-Label, Single-Arm Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Moderate-to-Severe Plaque Psoriasis in a Canadian Population.
17:129-138.
2013
-
Surface Anatomy of the Nose for the Dermatologist.
17:143-146.
2013
-
Etanercept Improves Quality of Life Outcomes and Treatment Satisfaction in Patients with Moderate to Severe Plaque Psoriasis in Clinical Practice.
16:407-416.
2012
-
Etanercept Improves Quality of Life Outcomes and Treatment Satisfaction in Patients with Moderate to Severe Plaque Psoriasis in Clinical Practice.
16:407-416.
2012
-
Comparison of Dermatologists' and Nondermatologists' Diagnostic Accuracy for Malignant Melanoma.
16:272-280.
2012
-
Unilateral Keratoderma in a Mother and Her Son.
16:288-290.
2012
-
Impact of the Number of Dermatologists on Dermatology Biomedical Research: A Canadian Study.
16:174-179.
2012
-
Sweet Syndrome and Pemphigus Vulgaris.
16:128-130.
2012
-
Figurate Erythema: An Unusual Presentation of the Nonbullous Phase of Bullous Pemphigoid.
16:61-63.
2012
-
Figurate Erythema: An Unusual Presentation of the Nonbullous Phase of Bullous Pemphigoid.
16:61-63.
2012
-
Impact of the number of dermatologists on dermatology biomedical research: a Canadian study..
16:174-179.
2012
-
Topical Psoriasis Therapy in the Age of Biologics: Evidence-Based Treatment Recommendations.
15:309-321.
2011
-
Gourmet Clinical Pearls.
15:63-64.
2011
-
Drug-Induced Lichenoid Dermatitis with Histopathologic Features of Mycosis Fungoides in a Patient with Psoriasis.
14:307-309.
2010
-
Antepartum Intravenous Immunoglobulin Therapy in Refractory Pemphigoid Gestationis: Case Report and Literature Review.
14:189-192.
2010
-
Are Excipients Really Inert Ingredients? A Review of Adverse Reactions to Excipients in Oral Dermatologic Medications in Canada.
14:105-114.
2010
-
Efficacy Outcomes in Patients Using Alefacept in the AWARE Study.
13:S122-S130.
2009
-
Adalimumab in the Treatment of Psoriasis: Pooled Efficacy and Safety Results from Three Pivotal Studies.
13:S58-S66.
2009
-
Skin Thickening in a Hemodialysis Patient: A Case of Nephrogenic Fibrosing Dermopathy.
13:110-114.
2009
-
Nail Psoriasis and Biologics.
13:1-5.
2009
-
Occurrence of Plantar Pustular Psoriasis during Treatment with Infliximab.
13:40-42.
2009
-
Practical Understanding of Mean Percent Psoriasis Area and Severity Index Reduction for Biologics.
12:282-287.
2008
-
Are All Seborrheic Keratoses Benign? Review of the Typical Lesion and Its Variants.
12:203-210.
2008
-
Divergence of Demographic Factors Associated with Clinical Severity Compared with Quality of Life Impact in Acne.
12:235-242.
2008
-
Miliarial Gout (A New Entity).
11:31-34.
2007
-
Antihistamines in the Treatment of Atopic Dermatitis.
7:467-473.
2003
-
When Is Recalcitrant Pyoderma Gangrenosum Truly Recalcitrant?.
7:387-389.
2003
-
When is Recalcitrant Pyoderma Gangrenosum Truly Recalcitrant?.
7:387-389.
2003
-
Mycophenolate Mofetil (CellCept�) for Psoriasis: A Two-Center, Prospective, Open-Label Clinical Trial.
7:193-197.
2003
-
Treatment of Self-Mutilation with Olanzapine.
4:160-162.
2000
-
Treatment of self-mutilation with olanzapine..
4:161-163.
2000
-
Role of the Cyclin-Dependent Kinase Inhibitor CDKN2A in Familial Melanoma.
2:172-179.
1998
-
The future of surgical versus medical dermatology.
1:216-218.
1997
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)